Amyloid beta oligomers induce impairment of neuronal insulin receptors

Zhao, Wei‐Qin, De Felice, Fernanda G., Fernandez, Sara, Chen, Hui, Lambert, Mary P., Quon, Michael J., Krafft, Grant A., Klein, William L.·2008·The FASEB Journal
DOI 10.1096/fj.06-7703com

Cited by (590)

Items 501–590 of 590

  1. Risk Factors for Alzheimer’s Disease
    A. A. Farooqui · 2017 · Elsevier eBooks
  2. Heat Therapy with Relevance to the Reversal of NAFLD and Diabetes
    Ian James Martins · 2017 · Diabetes & Metabolic Disorders
  3. Relation mutuelle entre Tau et signalisation centrale de l’insuline
    Aurélie Joly‐Amado, Maud Gratuze, Hamza Benderradji, Didier Vieau, Luc Buée, David L Blum · 2018 · médecine/sciences
  4. Association of circadian dysregulation with retinal degeneration and Alzheimer’s disease: a special focus on Muller glial cells
    Glori Das, Thomas E. Milner · 2024 · Frontiers in Photonics
  5. T-regulatory cells and extracellular vesicles in Alzheimer’s disease: New therapeutic concepts and hypotheses
    Ricardo Augusto Leoni De Sousa, Bruno Ferreira Mendes · 2024 · Brain Research
  6. Brain insulin resistance as an early target to attenuate neuroinflammation, oxidative stress and proteinopathies in Alzheimer’s disease: A systematic review of five natural products
    Reem A. Mohamed, Radwa H. Abdelaziz, Mohamed S. Mohamed, Nayra H. Ahmed, Rouz M. Ahmed · 2025 · Next research.
  7. Oleanolic Acid and Alzheimer’s Disease: Mechanistic Hypothesis of Therapeutic Potential
    Juan Manuel Espinosa-Cabello, Ángel Fernández‐Aparicio, Emilio González‐Jiménez, Gisela Perez-Muñoz, José M. Castellano, Javier S. Perona · 2026 · Applied Sciences
  8. Acute amyloid-β exposure disrupts insulin signaling in hCMEC/D3 blood–brain barrier endothelial cells
    Douglas A. Nelson, Suresh Kumar Swaminathan, Vaishnavi Veerareddy, Hannah S. Seo, Samira M. Azarin, Krishna R. Kalari, Karunya K. Kandimalla · 2026 · Fluids and Barriers of the CNS
  9. Glucagon-Like Peptide-1 Signaling in Learning and Memory: Evidence, Mechanisms, and Therapeutic Implications
    Alexander G. Bashaw, Ciorana Roman-Ortiz, Serena X. Gao, Lindsey A. Schier, Tito Borner, Scott E. Kanoski · 2026 · Biological Psychiatry
  10. Neurochemical Aspects of Alzheimer Disease
    A. A. Farooqui · 2016 · Springer eBooks
  11. Glucose, glycolysis, and neurodegenerative disorders
    Patrícia Coelho, Ana Cristina Rego · 2023 · Elsevier eBooks
  12. Action and Interaction of Amyloid-β and Insulin on Dopamine Release and Reuptake in the Dorsal Lateral Striatum of Rats
    Valery N. Mukhin, Ivan R. Borovets, Vadim V. Sizov, В. М. Клименко · 2024 · Journal of Evolutionary Biochemistry and Physiology
  13. Efficacy of Stem Cell-derived Extracellular Vesicles in the Treatment of Alzheimer's Disease Model Mice: A Systematic Review and Meta-analysis
    Qinpin Zheng, Sensen Wang, Tian Wang, Guirong Zhang · 2025 · Current Stem Cell Research & Therapy
  14. Targeting Aβ Receptors to Modify Alzheimer’s Disease Progression
    Laura T. Haas, Stephen M. Strittmatter · 2016 · Elsevier eBooks
  15. Oxidative Stress, Metabolic Syndrome and Alzheimer’s Disease
    Danira Toral-Ríos, Karla Carvajal, Bryan Víctor Phillips-Farfán, Luz Camacho, Victoria Campos‐Peña · 2016 · Springer eBooks
  16. Cerebral insulin resistance: current concepts of the pathogenesis and possible therapeutic strategies
    Radiy Germanovich Esin, И Х Хайруллин, Oleg Radievich Esin · 2018 · S S Korsakov Journal of Neurology and Psychiatry
  17. Effects of Chronic Administration of Pioglitazone on Learning and Memory in Rat Model of Streptozotocin-induced Alzheimer’s Disease
    Ehsan Aali, Mohammad Hossein Esmaeili, Sead Shima Mahmodi, Poriea Solimani · 2020 · The Journal of Qazvin University of Medical Sciences
  18. Brain Hydrophobic Peptides Antagonists of Neurotoxic Amyloid β Peptide Monomers/Oligomers–Protein Interactions
    Carlos Gutiérrez‐Merino · 2023 · International Journal of Molecular Sciences
  19. MicroRNA cargo in neuron‐derived vesicles as peripheral biomarkers of brain insulin dysregulation
    Jacob Alexander Cleary, Ashish Kumar, Yixin Su, Sangeeta Singh, Fang‐Chi Hsu, Suzanne Craft, William Harrison, Christopher Dirk Keene, Marjorie J. Howard, Kathleen M. Hayden et al. · 2025 · Alzheimer s & Dementia
  20. Insulin resistance as a mediator of physical activity's effects on beta-amyloid accumulation and tau phosphorylation: A scoping review
    Michael G Slee, Joanne Scotney, Stephanie Ruth Rainey‐Smith, Kirk I. Erickson, Hamid Reza Sohrabi, Giuseppe Verdile, Belinda M. Brown · 2025 · Ageing Research Reviews
  21. Proposed unified model of late-onset Alzheimer's disease: Chronic astrocytic and neuronal bioenergetic failure
    James P Garrahy · 2025 · Journal of Alzheimer s Disease
  22. Fisetin targets multiple signaling pathways to suppress microglia-mediated neuroinflammation and cognitive decline in Alzheimer's disease
    Yu-Ting Dai, Qian Chen, Yan-Dong Ma, Hang Liu, Handan Zheng, Yi-Yi Zhu, Lei Gao, Qin Zhao, Jie-Lin Bai, Yu-Chen Fan et al. · 2026 · Neuropharmacology
  23. Combating ageing beyond the cell: Emerging roles of extracellular proteostasis
    Siddharth R. Venkatesh, Ivan Gallotta, Bolanle Fatimat Olabiyi, Yoon Hee Choi, Sarah Inglesfield, Janet R. Kumita, Collin Y. Ewald, Della C. David · 2026 · FEBS Journal
  24. Genetic Risk Factors: Their Function and Comorbidities in Alzheimer′s Disease
    Mikko O. Hiltunen, Lars Bertram, Aleister J. Saunders · 2011 · International Journal of Alzheimer s Disease
  25. Biological Targeting and Activity of Pre-fibrillar Aβ Assemblies
    Kyle C. Wilcox, Jason E. Pitt, Adriano Silva Sebollela, Helen Martirosova, Pascale N. Lacor, William L. Klein · 2011 · Springer eBooks
  26. The effect of metformin on memory retention of inhibitory avoidance learning in streptozotocin-induced rat model of alzheimer’s disease
    Mohammad Hossein Esmaeili, Mafe Esmaeili Mahin · 2015 · KAUMS Journal
  27. Amyloid Hypothesis: Molecular and Cellular Aspects of Toxicity
    Rakez Kayed, Cristian A. Lasagna‐Reeves · 2013 · Modecular medicine and medicinal
  28. Diet, Abeta Oligomers and Defective Insulin and Neurotrophic Factor Signaling in Alzheimer’s Disease
    Greg M. Cole, Qiu‐Lan Ma, Fusheng Yang, Atul M. Deshpande, Oliver J. Ubeda, Sally Ann Frautschy · 2010 · Research and perspectives in Alzheimer's disease
  29. Effects of Long Term Consumption of High Calorie Diet on Neurological Disorders
    A. A. Farooqui · 2015 · Springer eBooks
  30. Type 2 diabetes mellitus, drug addiction, bipolar disorder and epilepsy display overlapping aetiopathogenic mechanisms: Implication for prevention and pharmacotherapy
    S. E. Oriaifo · 2015 · International Research Journal of Medicine and Medical Sciences
  31. An Investigation on the Fundamental Interaction between Abeta Peptides and the AT-Rich DNA
    Li Na Zhao, Jie Zheng, Lock Yue Chew, Yuguang Mu · 2015 · The Journal of Physical Chemistry B
  32. NEUROINFLAMMATION AND INSULIN RESISTANCE IN ALZHEIMER’S DISEASE
    Петрова М. М, Удк, При Болезни Альцгеймера · 2014 · CyberLeninK (CyberLeninka)
  33. Insulin resistance and Alzheimer’s disease
    A. A. Farooqui · 2020 · Elsevier eBooks
  34. Inflammation and insulin resistance in Alzheimer’s disease
    Yuval Nash, Dan Frenkel · 2020 · Elsevier eBooks
  35. Roundoc Rx: Inflammation and Functional Medicine Interventions: Part 1—Inflammation and Chronic Disease
    ROBERT L. ROUNTREE · 2010 · Alternative and Complementary Therapies
  36. Protective Roles of the Incretin Hormones Glucagon-Like Peptide-1 and Glucose-Dependent Insolinotropic Polypeptide Hormones in Neurodegeneration
    Christian Hölscher · 2011 · InTech eBooks
  37. Glucose facilitates Aβ oligomerization and tau phosphorylation in C. elegans model of Alzheimer’s disease
    Waqar Ahmad · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  38. Protein Misfolding and Disease
    Johanna C. Scheinost, Grant E. Boldt, Paul Wentworth · 2012 · Chemical biology
  39. Complications of Diabetes Mellitus and their Pathophysiology
    Richard F. Dods · 2013
  40. Roles of Glucagon‐Like Peptide and Glucose‐Dependent Insolinotropic Polypeptide Hormones in Brain Function and Neurodegeneration
    Christian Hölscher · 2012 · Wiley eBooks
  41. The Janus Face of Insulin in Brain
    Ana Isabel Duarte, Emanuel Candeias, Sónia C. Correia, Renato X. Santos, Cristina Carvalho, Susana Cardoso, Ana I. Plácido, Maria S. Santos, Catarina Resende Oliveira, Paula Isabel Moreira · 2013 · Wiley eBooks
  42. Protein Misfolding and Disease
    Johanna C. Scheinost, Grant E. Boldt, Paul Wentworth · 2008 · Wiley eBooks
  43. Modulation of Cognition by Insulin and Aging: Implications for Alzheimer Disease
    Maite Solas, María Javier Ramírez · 2013 · Wiley eBooks
  44. Physico-chemical characterization of beta-amyloid oligomers and study of their function in biological processes at molecular level
    Dóra Simon · 2011 · SZTE Repository of Dissertations (University of Szeged)
  45. Type 2 Diabetes and Dementia
    Mark W. J. Strachan · 2011 · Springer eBooks
  46. Molecular changes during the development of Alzheimer's disease
    Kerstin T.S. Wirz · 2013 · Data Archiving and Networked Services (DANS)
  47. Multi-tasking, Executive Function, and Functional Abilities in Older Adults with Type 2 Diabetes Mellitus
    JASON L. RUCKER · 2014 · KU ScholarWorks (The University of Kansas)
  48. Review article: ROLE OF ANTI-DIABETIC DRUGS AS THERAPEUTIC AGENTS IN ALZHEIMER'S DISEASE
    Syed Mohd, Danish Raza Rizvi, Sibhghatulla Shaikh, Shah Mohammad Abbas Waseem, Shazi Shakil, Adel Mohammed Abuzenadah, Deboshree Biswas, Shams S. M. Tabrez, Mohammad Amjad Kamal, Saudi Arabia · 2015
  49. Inflammation, Defective Insulin Signaling, and Mitochondrial Dysfunction as Common Molecular Denominators Connecting Type 2 Diabetes to
    Fernanda G. De Felice, Sergio Teixeira Ferreira · 2014
  50. Investigation on the mechanism of amyloid beta peptides oligomerization and the process for its inhibition
    Li Na Zhao · 2013
  51. Using TUDCA to treat Alzheimer's disease after pathology onset in APP/PS1 mice
    Pedro Dionísio · 2014 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  52. Señalización por insulina en el cerebro y su participación en la enfermedad de Alzheimer
    David Heras-Sandoval, Clorinda Arias · 2009
  53. THE EFFECT OF METFORMIN ON SPATIAL LEARNING AND MEMORY IN STREPTOZOTOCIN RAT MODEL OF ALZHEIMER'S DISEASE
    Maryam Khosravi, Mohammad Hossein Esmaeili, Mafe Esmaeili Mahin · 2014
  54. Using TUDCA to treat Alzheimer's disease after pathology onset in APP/PS1 mice
    Faculdade De Farmácia · 2014
  55. Effects of Curcumin on Oxidative Stress in Animal Models and Patients with Alzheimer Disease
    A. A. Farooqui · 2016 · Springer eBooks
  56. Mechanisms of amyloid-beta cytotoxicity in hippocampal network function : rescue strategies in Alzheimer's disease
    Firoz Roshan Kurudenkandy · 2016 · Figshare
  57. Type II Diabetes and Metabolic Syndrome as Risk Factors for Alzheimer’s Disease
    A. A. Farooqui · 2017 · Elsevier eBooks
  58. Perspective, Summary, and Directions for Future Research on Alzheimer’s Disease
    A. A. Farooqui · 2017 · Elsevier eBooks
  59. Interactions Between Age, Diet, and Insulin and Their Effect on Cognition
    Elisa Félix‐Soriano, María Jesús Moreno-Aliaga, María Javier Ramírez, Maite Solas · 2018 · Elsevier eBooks
  60. Estudo comparativo da neuroproteção por anticorpos anti-A? contra a toxicidade de oligômeros de A? em cultura diferenciada de neuroblastoma humano
    Nathalia Reges Pinheiro · 2018 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  61. Terapia celular y génica con timulina E IGF-1 en modelos animales de neuroinflamación
    María Florencia Zappa Villar · 2018 · El Servicio de Difusión de la Creación Intelectual (National University of La Plata)
  62. Strategy for Peptide Drug Delivery via Nose-to-Brain Transport Pathways: Challenges to Pharmacotherapy for Dementia
    Noriyasu Kamei, Mariko Takeda‐Morishita · 2019 · Drug Delivery System
  63. Effects of anle138b treatment on amyloid-β neurotoxicity
    Carolina Thomas · 2020 · eDiss (Georg-August-Universität Göttingen)
  64. Alzheimer-associated Ab oligomers impact the central nervous system to induce peripheral metabolic deregulation
    Julia Rosauro Clarke, Natalia M. Lyra e Silva, Cláudia Pinto Figueiredo, Rudimar Luiz Frozza, José Henrique Ledo, Danielle Beckman, Carlos K. Katashima, Daniela Soares Razolli, Bruno M. Carvalho, Renata Frazão et al. · 2015 · Americanae (AECID Library)
  65. Strain-specific profiling of Amyloid-β in Alzheimer´s disease: functional and clinical signature
    Aneeqa Noor · 2020 · eDiss (Georg-August-Universität Göttingen)
  66. Faculty Opinions recommendation of Cellular prion protein is essential for oligomeric amyloid-β-induced neuronal cell death.
    Gerald Werner Zamponi · 2012 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  67. Monomeric ß-Amyloid Interacts with Type-1 Insulin-Like Growth Factor Receptors to Provide Energy Supply to Neurons
    Maria Laura Giuffrida, Marianna Flora Tomasello, Giuseppe Pandini, Filippo Caraci, Giuseppe Battaglia, Carla Letizia Busceti, Paola Di Pietro, Giuseppe Pappalardo, Francesco Attanasio, Santina Chiechio et al. · 2020 · Vide Leaf, Hyderabad eBooks
  68. 嗅神経を介した薬物送達システム
    英明 志賀, 三輪 高喜 · 2021 · Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology)
  69. Caracterização preliminar do isolamento de oligômeros do peptídeo β-amiloide utilizando o anticorpo de cadeia única NUsc1
    Raquel Maria de Campos · 2018 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  70. Diabetes tipo III: mito ou realidade?
    Jefferson Petto · 2017 · Revista Brasileira de Fisiologia do Exercício
  71. Insulin and neurodegenerative diseases
    Heather Anne Ferris · 2023 · Elsevier eBooks
  72. Additional file 3 of Prediction of differentially expressed microRNAs in blood as potential biomarkers for Alzheimer’s disease by meta-analysis and adaptive boosting ensemble learning
    Sze Chung Yuen, Xiaonan Liang, Hongmei Zhu, Yongliang Jia, Siu-wai Leung · 2021 · Figshare
  73. Additional file 2 of Prediction of differentially expressed microRNAs in blood as potential biomarkers for Alzheimer’s disease by meta-analysis and adaptive boosting ensemble learning
    Sze Chung Yuen, Xiaonan Liang, Hongmei Zhu, Yongliang Jia, Siu-wai Leung · 2021 · Figshare
  74. Additional file 1 of Prediction of differentially expressed microRNAs in blood as potential biomarkers for Alzheimer’s disease by meta-analysis and adaptive boosting ensemble learning
    Sze Chung Yuen, Xiaonan Liang, Hongmei Zhu, Yongliang Jia, Siu-wai Leung · 2021 · Figshare
  75. Associations between novel anthropometric indices and cognitive function among U.S. older adults
    Zhichun Tan, Hongmei Deng, Yaxin Nie, Ning Yan, Lixin Ai · 2024 · Research Square
  76. ACUTE AMYLOID-Β 40 EXPOSURE DISRUPTS METABOLIC INSULIN SIGNALING IN BLOOD-BRAIN BARRIER ENDOTHELIAL CELLS
    Douglas B. Nelson, Krishna R. Kalari, Karunya K. Kandimalla · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  77. Epidemiology related to confluence of diabetes and Alzheimer
    Pushpa Yadav, Priya Singh · 2025 · Elsevier eBooks
  78. Altered cell signaling linked to neurodegeneration : Studies on scrapie-infected neuroblastoma cells and activated microglia
    C. Svensson · 2011 · DiVA (Stockholm University)
  79. Additional file 1 of Type 2 diabetes mellitus-associated transcriptome alterations in cortical neurones and associated neurovascular unit cells in the ageing brain
    Joanna J. Bury, Annabelle Chambers, Paul Roy Heath, Paul G. Ince, Shaw, Pamela J., Fiona Matthews, Carol Brayne, Julie E. Simpson, Stephen B. Wharton · 2021 · Figshare
  80. Additional file 2 of Type 2 diabetes mellitus-associated transcriptome alterations in cortical neurones and associated neurovascular unit cells in the ageing brain
    Joanna J. Bury, Annabelle Chambers, Paul Roy Heath, Paul G. Ince, Shaw, Pamela J., Matthews, Fiona E., Carol Brayne, Julie E. Simpson, Stephen B. Wharton · 2021 · Figshare
  81. Additional file 3 of Type 2 diabetes mellitus-associated transcriptome alterations in cortical neurones and associated neurovascular unit cells in the ageing brain
    Joanna J. Bury, Annabelle Chambers, Paul Roy Heath, Paul G. Ince, Shaw, Pamela J., Matthews, Fiona E., Carol Brayne, Julie E. Simpson, Stephen B. Wharton · 2021 · Figshare
  82. Cognitive decline and neurodegenerative risk in diabetes and aging
    Janvi Sharma, Pooja Devi, Amit Gupta, Chinmoyee Maharana · 2026 · Elsevier eBooks
  83. Etude préclinique et clinique de la phase précoce de la maladie d'Alzheimer
    Stéphane Epelbaum · 2015 · theses.fr (ABES)
  84. Caractérisation des mécanismes moléculaires impliqués dans la mise en place des altérations cérébrales dans un modèle préclinique de diabète de type 2
    Rim Hamzé · 2023 · theses.fr (ABES)
  85. From molecules to behavior : network effects of Alzheimer's disease-associated amyloid beta peptides in a Drosophila melanogaster larval circuit
    Anqi Zhou · 2024 · theses.fr (ABES)
  86. Metabolic dysregulation in Alzheimer’s disease: Mechanisms, markers, and therapeutic prospects
    Radhika Mittal, Priya, Jyotirmoy Banerjee, Aparna Dixit · 2026 · International review of neurobiology
  87. Insulin Action in the Brain
    Heather A. Ferris · 2026 · Elsevier eBooks
  88. MiR-7 in neurological disorders: beyond metabolic dysregulation
    Cristina Puigdueta, Virginia Pardo, Marta Torrecilla-Parra, Mario Fernández-de Frutos, José Luis López-Aceituno, Carmen Zamora, Yaiza López-Manchedo, Rebeca Busto, Cristina M. Ramírez · 2026 · Frontiers in Neuroscience
  89. The interstitial fluid dynamics and diabetes mellitus
    Rukeye Tuerxun, Kaito Takabayashi, Takafumi Kitagawa, Rui Zou, Koyo Mizuta, Koji Kamagata · 2026 · Elsevier eBooks
  90. Targeting insulin resistance with exercise mimetics: A potential therapeutic strategy for Alzheimer's disease
    Huanhuan Shi, Zhiwei Ke, Bo Wang, Xinan Zhang, Yang Gui, Hu Zhang, Rongxiang Liang · 2026 · Experimental Neurology